EDGAR Filing Documents for 0001387131-20-007827

Form 8-K - Current report:

SEC Accession No. 0001387131-20-007827

Filing Date

2020-08-24

Accepted

2020-08-24 16:36:37

Documents

Period of Report

2020-08-20

Items

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	CURRENT REPORT	admp-8k_082020.htm iXBRL	8-K	41486
2	2020 EQUITY INCENTIVE PLAN	ex10-1.htm	EX-10.1	203731
	Complete submission text file	0001387131-20-007827.txt		465754

Data Files

Seq	Description	Document	Type	Size
3	XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT	admp-20200820.xsd	EX-101.SCH	3225
4	XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT	admp-20200820_lab.xml	EX-101.LAB	34591
5	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT	admp-20200820_pre.xml	EX-101.PRE	22736
6	EXTRACTED XBRL INSTANCE DOCUMENT	admp-8k_082020_htm.xml	XML	3595

Mailing Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130

Business Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 997-2400

Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)